Boston biotech Beam Therapeutics has announced initial data from a phase 1/2 trial of its gene therapy for a genetic lung and liver disease, with no serious adverse events reported among the nine ...

Preliminary results from a small clinical trial suggest that a cutting-edge genetic medicine developed by Beam Therapeutics can repair the damaged DNA that gives rise to a rare liver and lung disorder ...

I created the BEAM model to offer a structured approach to increasing self-awareness, improving decision-making and fostering intentional leadership. 1. Beliefs: We all perceive the world through ...